Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Retained Earnings (2023 - 2025)

Historic Retained Earnings for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $456.7 million.

  • Ardent Health's Retained Earnings rose 8150.46% to $456.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $456.7 million, marking a year-over-year increase of 8150.46%. This contributed to the annual value of $365.8 million for FY2024, which is 13530.97% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Retained Earnings is $456.7 million, which was up 8150.46% from $480.1 million recorded in Q2 2025.
  • Over the past 5 years, Ardent Health's Retained Earnings peaked at $480.1 million during Q2 2025, and registered a low of $155.5 million during Q4 2023.
  • Over the past 3 years, Ardent Health's median Retained Earnings value was $365.8 million (recorded in 2024), while the average stood at $334.6 million.
  • As far as peak fluctuations go, Ardent Health's Retained Earnings surged by 13530.97% in 2024, and later skyrocketed by 8150.46% in 2025.
  • Ardent Health's Retained Earnings (Quarter) stood at $155.5 million in 2023, then soared by 135.31% to $365.8 million in 2024, then rose by 24.84% to $456.7 million in 2025.
  • Its Retained Earnings stands at $456.7 million for Q3 2025, versus $480.1 million for Q2 2025 and $407.2 million for Q1 2025.